Nisa Investment Advisors, LLC Sage Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 740 shares of SAGE stock, worth $3,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares

740

Previous 6,230 88.12%

Holding current value

$3,907

Previous $67,000 92.54%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$7.02 - $13.08 $38,539 - $71,809	-5,490 Reduced 88.12%	740 $5,000
Q2 2024 Jul 19, 2024	SELL	$10.58 - $17.9 $136,323 - $230,641	-12,885 Reduced 67.41%	6,230 $67,000
Q1 2024 May 01, 2024	BUY	$18.62 - $26.95 $1,396 - $2,021	75 Added 0.39%	19,115 $358,000
Q4 2023 Jan 25, 2024	BUY	$17.1 - $22.26 $316,179 - $411,587	18,490 Added 3361.82%	19,040 $412,000
Q3 2023 Nov 02, 2023	SELL	$16.75 - $48.98 $24,773 - $72,441	-1,479 Reduced 72.89%	550 $11,000
Q2 2023 Aug 11, 2023	BUY	$40.65 - $59.54 $21,951 - $32,151	540 Added 36.27%	2,029 $95,000
Q4 2022 Feb 02, 2023	SELL	$32.2 - $43.61 $4,508 - $6,105	-140 Reduced 8.59%	1,489 $57,000
Q3 2022 Nov 07, 2022	BUY	$32.28 - $43.27 $2,905 - $3,894	90 Added 5.85%	1,629 $61,000
Q2 2022 Aug 03, 2022	BUY	$27.52 - $37.99 $39,904 - $55,085	1,450 Added 1629.21%	1,539 $50,000
Q1 2022 Apr 29, 2022	SELL	$30.71 - $45.71 $3,838 - $5,713	-125 Reduced 58.41%	89 $3,000
Q4 2021 Feb 03, 2022	SELL	$37.06 - $47.11 $4,484 - $5,700	-121 Reduced 36.12%	214 $8,000
Q3 2021 Oct 18, 2021	SELL	$40.26 - $57.37 $68,522 - $97,643	-1,702 Reduced 83.55%	335 $15,000
Q2 2021 Aug 06, 2021	SELL	$54.88 - $79.29 $49,392 - $71,361	-900 Reduced 30.64%	2,037 $116,000
Q4 2020 Jan 25, 2021	BUY	$58.41 - $89.06 $111,679 - $170,282	1,912 Added 186.54%	2,937 $254,000
Q2 2020 Jul 27, 2020	SELL	$25.95 - $43.15 $96,793 - $160,949	-3,730 Reduced 78.44%	1,025 $43,000
Q1 2020 Apr 17, 2020	BUY	$26.15 - $77.24 $19,612 - $57,929	750 Added 18.73%	4,755 $137,000
Q4 2019 Jan 17, 2020	SELL	$60.18 - $154.77 $767,896 - $1.97 Million	-12,760 Reduced 76.11%	4,005 $289,000
Q3 2019 Oct 17, 2019	BUY	$140.29 - $189.96 $2.33 Million - $3.15 Million	16,590 Added 9480.0%	16,765 $2.35 Million
Q1 2019 Apr 17, 2019	SELL	$89.33 - $163.65 $172,406 - $315,844	-1,930 Reduced 91.69%	175 $28,000
Q3 2018 Oct 16, 2018	BUY	$138.11 - $169.04 $266,552 - $326,247	1,930 Added 1102.86%	2,105 $297,000
Q2 2018 Jul 19, 2018	SELL	$140.36 - $175.76 $31,581 - $39,546	-225 Reduced 56.25%	175 $27,000
Q1 2018 Apr 10, 2018	SELL	$152.15 - $192.33 $7,607 - $9,616	-50 Reduced 11.11%	400 $64,000
Q4 2017 Jan 12, 2018	BUY	$60.72 - $167.34 $2,428 - $6,693	40 Added 9.76%	450 $74,000
Q3 2017 Oct 13, 2017	BUY	$61.4 - $88.52 $25,174 - $36,293	410	410 $26,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $314M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Sage Therapeutics, Inc. Transaction History